Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-dose, Two-sequence, Four-Period, Fully Replicated Crossover Bioequivalence Study of Dabigatran Etexilate Mesylate Capsules in Healthy Subjects Under Fasting and Fed Conditions

NCT06876623 is registered in ClinicalTrials.gov with The Affiliated Hospital Of Guizhou Medical University as lead sponsor.

NCT NCT06876623
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06876623 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-dose, Two-sequence, Four-Period, Fully Replicated Crossover Bioequivalence Study of Dabigatran Etexilate Mesylate Capsules in Healthy Subjects Under Fasting and Fed Conditions
Lead sponsor
The Affiliated Hospital Of Guizhou Medical University
Phase
Phase 1
Overall status
Completed
Start date
December 10, 2019
Completion date
June 12, 2020
Enrollment
88 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bioequivalence of dabigatran etexilate mesylate capsules from two different manufacturers in healthy chinese subjects